This project aims to investigate the function of the receptors for granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and interleukin-5 (IL-5). These factors exert strong proliferative and differentiative effects on myeloid haemopoietic cells. Moreover, autocrine GM-CSF production has been implicated in some leukemias and IL-5 is involved in many allergic reactions, including asthma. The cell-surface receptors for GM-CSF, IL-3 and IL-5 are members of the cytokine receptor family and are comprised of two different subunits, alpha and beta. The alpha-subunit is unique to each factor while the beta- subunit (hbetac) is shared by the three factors. Specifically, it is proposed to utilise a unique set of constitutively active mutants of hbetac to examine the structure, assembly, composition and activity of the functional receptor complexes. These studies will test a model that predicts that hbetac can form intermediate, functional receptor complexes with distinct properties. This studies will be carried out by: (i) Examination of the composition and structure of activated hbetac complexes, in particular those comprising constitutive mutants of hbetac. (ii) Establishing the role of the alpha-subunit in receptor activation. (iii) Examination of the role, in activation and signalling, of molecules associated with the receptor complexes (iv) Examination of the nature and role of cross-activation of EpoR (v) Examination of lipid modification of hbetac and its effects on membrane localisation. In addition, it is proposed that novel reagents (eg. monoclonal antibodies) can be generated which interact with critical regions of hbetac and can trigger signalling activity in the absence of cytokine.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL060657-07
Application #
6619675
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Thomas, John
Project Start
1998-08-01
Project End
2004-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
7
Fiscal Year
2003
Total Cost
$175,000
Indirect Cost
Name
Women's & Children's Health Research/Institute
Department
Type
DUNS #
751800541
City
Adelaide
State
Country
Australia
Zip Code
Brown, Anna L; Salerno, Diana G; Sadras, Teresa et al. (2012) The GM-CSF receptor utilizes ?-catenin and Tcf4 to specify macrophage lineage differentiation. Differentiation 83:47-59
Perugini, Michelle; Brown, Anna L; Salerno, Diana G et al. (2010) Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. Blood 115:3346-53
Perugini, M; Kok, C H; Brown, A L et al. (2009) Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation. Leukemia 23:729-38
Brown, Anna L; Wilkinson, Christopher R; Waterman, Scott R et al. (2006) Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling. J Leukoc Biol 80:433-47
D'Andrea, Richard J; Sadlon, Timothy J; Gonda, Thomas J (2004) Overlapping motifs in the membrane-proximal region of cytokine receptor accessory and signaling subunits. Cytokine Growth Factor Rev 15:83-5
McClure, B J; Woodcock, J M; Harrison-Findik, D et al. (2001) GM-CSF binding to its receptor induces oligomerisation of the common beta-subunit. Cytokine 13:240-3
Butcher, C; D'Andrea, R J (2000) Molecular aspects of polycythemia vera (review). Int J Mol Med 6:243-52
Mulhern, T D; Lopez, A F; D'Andrea, R J et al. (2000) The solution structure of the cytokine-binding domain of the common beta-chain of the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5. J Mol Biol 297:989-1001
D'Andrea, R J; Gonda, T J (2000) A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit. Exp Hematol 28:231-43